Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-30 4:29 pm Purchase | 2022-12-20 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Lynx1 Capital Management LP | 114,557 5.380% | 114,557 (New Position) | Filing History |
| 2022-07-19 4:08 pm Purchase | 2022-07-18 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Millennium Management LLC | 106,629 5.000% | 1,058 (+1.00%) | Filing History |
| 2022-07-15 4:04 pm Sale | 2022-07-07 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Millennium Management LLC | 105,571 4.970% | -269 (-0.25%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | BlackRock, Inc. BLK | 45,542 2.100% | -84,690 (-65.03%) | Filing History |
| 2022-07-07 4:56 pm Purchase | 2022-06-27 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Millennium Management LLC | 105,840 4.980% | 105,840 (New Position) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Redmile Group LLC | 216,078 9.900% | 6,295 (+3.00%) | Filing History |
| 2022-02-14 3:03 pm Sale | 2021-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | EcoR1 Capital, LLC | 43,031 2.000% | -113,104 (-72.44%) | Filing History |
| 2022-02-11 4:06 pm Sale | 2021-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Silva Manzano Daniel Adriano | 145,458 6.800% | -1,449 (-0.99%) | Filing History |
| 2022-02-11 4:06 pm Purchase | 2021-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Ulge Umut | 156,387 7.300% | 9,115 (+6.19%) | Filing History |
| 2022-02-10 11:10 am Purchase | 2022-02-10 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | PICTET ASSET MANAGEMENT SA | 128,714 6.070% | 128,714 (New Position) | Filing History |
| 2022-02-02 7:18 pm Sale | 2021-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | BlackRock, Inc. BLK | 130,232 6.100% | -4,014 (-2.99%) | Filing History |